 | • レポートコード：MRC2-11QY04421 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は紫斑治療のグローバル市場について調査・分析したレポートです。種類別（非血小板減少症、血小板減少症）市場規模、用途別（病院用、診療所用、家庭用、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別紫斑治療の競争状況、市場シェア ・世界の紫斑治療市場：種類別市場規模 2015年-2020年（非血小板減少症、血小板減少症） ・世界の紫斑治療市場：種類別市場規模予測 2021年-2026年（非血小板減少症、血小板減少症） ・世界の紫斑治療市場：用途別市場規模 2015年-2020年（病院用、診療所用、家庭用、その他） ・世界の紫斑治療市場：用途別市場規模予測 2021年-2026年（病院用、診療所用、家庭用、その他） ・北米の紫斑治療市場分析：米国、カナダ ・ヨーロッパの紫斑治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの紫斑治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の紫斑治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの紫斑治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bristol-Myers Squibb Company、Pfizer Inc.、GlaxoSmithKline Plc.、Novartis AG、Hovione、Sanofi Winthrop Industrie S.A.、Hoffman-L Roche、Amgen Inc.、Grifols Biologicals Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Purpura is a condition of red or purple discolored spots on the skin that do not blanch on applying pressure.
The globally market for purpura treatment is one of the steady growing markets. Purpura occurs when the blood vessels and blood pools under the human skin, result in purple spots on the skin. There are various causes for purpura disease such as disorders that affect blood clotting, weak blood vessels, inflammation in the blood vessels, telangiectasia or Ehlers-Danlos syndrome.
Market Analysis and Insights: Global Purpura Treatment Market
The global Purpura Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Purpura Treatment Scope and Market Size
Purpura Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Purpura Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bristol-Myers Squibb Company
Pfizer Inc.
GlaxoSmithKline Plc.
Novartis AG
Hovione
Sanofi Winthrop Industrie S.A.
Hoffman-L Roche
Amgen Inc.
Grifols Biologicals Inc.
Market segment by Type, the product can be split into
Non-thrombocytopenic
Thrombocytopenic
Market segment by Application, split into
Hospital Use
Clinic Use
Household
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Purpura Treatment Revenue
1.4 Market by Type
1.4.1 Global Purpura Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Non-thrombocytopenic
1.4.3 Thrombocytopenic
1.5 Market by Application
1.5.1 Global Purpura Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Use
1.5.3 Clinic Use
1.5.4 Household
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Purpura Treatment Market Perspective (2015-2026)
2.2 Global Purpura Treatment Growth Trends by Regions
2.2.1 Purpura Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Purpura Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Purpura Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Purpura Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Purpura Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Purpura Treatment Players by Market Size
3.1.1 Global Top Purpura Treatment Players by Revenue (2015-2020)
3.1.2 Global Purpura Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Purpura Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Purpura Treatment Market Concentration Ratio
3.2.1 Global Purpura Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Purpura Treatment Revenue in 2019
3.3 Purpura Treatment Key Players Head office and Area Served
3.4 Key Players Purpura Treatment Product Solution and Service
3.5 Date of Enter into Purpura Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Purpura Treatment Historic Market Size by Type (2015-2020)
4.2 Global Purpura Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Purpura Treatment Market Size by Application (2015-2020)
5.2 Global Purpura Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Purpura Treatment Market Size (2015-2020)
6.2 Purpura Treatment Key Players in North America (2019-2020)
6.3 North America Purpura Treatment Market Size by Type (2015-2020)
6.4 North America Purpura Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Purpura Treatment Market Size (2015-2020)
7.2 Purpura Treatment Key Players in Europe (2019-2020)
7.3 Europe Purpura Treatment Market Size by Type (2015-2020)
7.4 Europe Purpura Treatment Market Size by Application (2015-2020)
8 China
8.1 China Purpura Treatment Market Size (2015-2020)
8.2 Purpura Treatment Key Players in China (2019-2020)
8.3 China Purpura Treatment Market Size by Type (2015-2020)
8.4 China Purpura Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Purpura Treatment Market Size (2015-2020)
9.2 Purpura Treatment Key Players in Japan (2019-2020)
9.3 Japan Purpura Treatment Market Size by Type (2015-2020)
9.4 Japan Purpura Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Purpura Treatment Market Size (2015-2020)
10.2 Purpura Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Purpura Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Purpura Treatment Market Size by Application (2015-2020)
11 India
11.1 India Purpura Treatment Market Size (2015-2020)
11.2 Purpura Treatment Key Players in India (2019-2020)
11.3 India Purpura Treatment Market Size by Type (2015-2020)
11.4 India Purpura Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Purpura Treatment Market Size (2015-2020)
12.2 Purpura Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Purpura Treatment Market Size by Type (2015-2020)
12.4 Central & South America Purpura Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bristol-Myers Squibb Company
13.1.1 Bristol-Myers Squibb Company Company Details
13.1.2 Bristol-Myers Squibb Company Business Overview
13.1.3 Bristol-Myers Squibb Company Purpura Treatment Introduction
13.1.4 Bristol-Myers Squibb Company Revenue in Purpura Treatment Business (2015-2020))
13.1.5 Bristol-Myers Squibb Company Recent Development
13.2 Pfizer Inc.
13.2.1 Pfizer Inc. Company Details
13.2.2 Pfizer Inc. Business Overview
13.2.3 Pfizer Inc. Purpura Treatment Introduction
13.2.4 Pfizer Inc. Revenue in Purpura Treatment Business (2015-2020)
13.2.5 Pfizer Inc. Recent Development
13.3 GlaxoSmithKline Plc.
13.3.1 GlaxoSmithKline Plc. Company Details
13.3.2 GlaxoSmithKline Plc. Business Overview
13.3.3 GlaxoSmithKline Plc. Purpura Treatment Introduction
13.3.4 GlaxoSmithKline Plc. Revenue in Purpura Treatment Business (2015-2020)
13.3.5 GlaxoSmithKline Plc. Recent Development
13.4 Novartis AG
13.4.1 Novartis AG Company Details
13.4.2 Novartis AG Business Overview
13.4.3 Novartis AG Purpura Treatment Introduction
13.4.4 Novartis AG Revenue in Purpura Treatment Business (2015-2020)
13.4.5 Novartis AG Recent Development
13.5 Hovione
13.5.1 Hovione Company Details
13.5.2 Hovione Business Overview
13.5.3 Hovione Purpura Treatment Introduction
13.5.4 Hovione Revenue in Purpura Treatment Business (2015-2020)
13.5.5 Hovione Recent Development
13.6 Sanofi Winthrop Industrie S.A.
13.6.1 Sanofi Winthrop Industrie S.A. Company Details
13.6.2 Sanofi Winthrop Industrie S.A. Business Overview
13.6.3 Sanofi Winthrop Industrie S.A. Purpura Treatment Introduction
13.6.4 Sanofi Winthrop Industrie S.A. Revenue in Purpura Treatment Business (2015-2020)
13.6.5 Sanofi Winthrop Industrie S.A. Recent Development
13.7 Hoffman-L Roche
13.7.1 Hoffman-L Roche Company Details
13.7.2 Hoffman-L Roche Business Overview
13.7.3 Hoffman-L Roche Purpura Treatment Introduction
13.7.4 Hoffman-L Roche Revenue in Purpura Treatment Business (2015-2020)
13.7.5 Hoffman-L Roche Recent Development
13.8 Amgen Inc.
13.8.1 Amgen Inc. Company Details
13.8.2 Amgen Inc. Business Overview
13.8.3 Amgen Inc. Purpura Treatment Introduction
13.8.4 Amgen Inc. Revenue in Purpura Treatment Business (2015-2020)
13.8.5 Amgen Inc. Recent Development
13.9 Grifols Biologicals Inc.
13.9.1 Grifols Biologicals Inc. Company Details
13.9.2 Grifols Biologicals Inc. Business Overview
13.9.3 Grifols Biologicals Inc. Purpura Treatment Introduction
13.9.4 Grifols Biologicals Inc. Revenue in Purpura Treatment Business (2015-2020)
13.9.5 Grifols Biologicals Inc. Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Purpura Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Purpura Treatment Revenue
Table 3. Ranking of Global Top Purpura Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Purpura Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Non-thrombocytopenic
Table 6. Key Players of Thrombocytopenic
Table 7. Global Purpura Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Purpura Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Purpura Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Purpura Treatment Market Share by Regions (2015-2020)
Table 11. Global Purpura Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Purpura Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Purpura Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Purpura Treatment Players
Table 18. Global Purpura Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Purpura Treatment Market Share by Players (2015-2020)
Table 20. Global Top Purpura Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Purpura Treatment as of 2019)
Table 21. Global Purpura Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Purpura Treatment Product Solution and Service
Table 24. Date of Enter into Purpura Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Purpura Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Purpura Treatment Market Size Share by Type (2015-2020)
Table 28. Global Purpura Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Purpura Treatment Market Size Share by Application (2015-2020)
Table 30. Global Purpura Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Purpura Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Purpura Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Purpura Treatment Market Share (2019-2020)
Table 34. North America Purpura Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Purpura Treatment Market Share by Type (2015-2020)
Table 36. North America Purpura Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Purpura Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Purpura Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Purpura Treatment Market Share (2019-2020)
Table 40. Europe Purpura Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Purpura Treatment Market Share by Type (2015-2020)
Table 42. Europe Purpura Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Purpura Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Purpura Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Purpura Treatment Market Share (2019-2020)
Table 46. China Purpura Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Purpura Treatment Market Share by Type (2015-2020)
Table 48. China Purpura Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Purpura Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Purpura Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Purpura Treatment Market Share (2019-2020)
Table 52. Japan Purpura Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Purpura Treatment Market Share by Type (2015-2020)
Table 54. Japan Purpura Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Purpura Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Purpura Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Purpura Treatment Market Share (2019-2020)
Table 58. Southeast Asia Purpura Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Purpura Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Purpura Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Purpura Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Purpura Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Purpura Treatment Market Share (2019-2020)
Table 64. India Purpura Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Purpura Treatment Market Share by Type (2015-2020)
Table 66. India Purpura Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Purpura Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Purpura Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Purpura Treatment Market Share (2019-2020)
Table 70. Central & South America Purpura Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Purpura Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Purpura Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Purpura Treatment Market Share by Application (2015-2020)
Table 74. Bristol-Myers Squibb Company Company Details
Table 75. Bristol-Myers Squibb Company Business Overview
Table 76. Bristol-Myers Squibb Company Product
Table 77. Bristol-Myers Squibb Company Revenue in Purpura Treatment Business (2015-2020) (Million US$)
Table 78. Bristol-Myers Squibb Company Recent Development
Table 79. Pfizer Inc. Company Details
Table 80. Pfizer Inc. Business Overview
Table 81. Pfizer Inc. Product
Table 82. Pfizer Inc. Revenue in Purpura Treatment Business (2015-2020) (Million US$)
Table 83. Pfizer Inc. Recent Development
Table 84. GlaxoSmithKline Plc. Company Details
Table 85. GlaxoSmithKline Plc. Business Overview
Table 86. GlaxoSmithKline Plc. Product
Table 87. GlaxoSmithKline Plc. Revenue in Purpura Treatment Business (2015-2020) (Million US$)
Table 88. GlaxoSmithKline Plc. Recent Development
Table 89. Novartis AG Company Details
Table 90. Novartis AG Business Overview
Table 91. Novartis AG Product
Table 92. Novartis AG Revenue in Purpura Treatment Business (2015-2020) (Million US$)
Table 93. Novartis AG Recent Development
Table 94. Hovione Company Details
Table 95. Hovione Business Overview
Table 96. Hovione Product
Table 97. Hovione Revenue in Purpura Treatment Business (2015-2020) (Million US$)
Table 98. Hovione Recent Development
Table 99. Sanofi Winthrop Industrie S.A. Company Details
Table 100. Sanofi Winthrop Industrie S.A. Business Overview
Table 101. Sanofi Winthrop Industrie S.A. Product
Table 102. Sanofi Winthrop Industrie S.A. Revenue in Purpura Treatment Business (2015-2020) (Million US$)
Table 103. Sanofi Winthrop Industrie S.A. Recent Development
Table 104. Hoffman-L Roche Company Details
Table 105. Hoffman-L Roche Business Overview
Table 106. Hoffman-L Roche Product
Table 107. Hoffman-L Roche Revenue in Purpura Treatment Business (2015-2020) (Million US$)
Table 108. Hoffman-L Roche Recent Development
Table 109. Amgen Inc. Business Overview
Table 110. Amgen Inc. Product
Table 111. Amgen Inc. Company Details
Table 112. Amgen Inc. Revenue in Purpura Treatment Business (2015-2020) (Million US$)
Table 113. Amgen Inc. Recent Development
Table 114. Grifols Biologicals Inc. Company Details
Table 115. Grifols Biologicals Inc. Business Overview
Table 116. Grifols Biologicals Inc. Product
Table 117. Grifols Biologicals Inc. Revenue in Purpura Treatment Business (2015-2020) (Million US$)
Table 118. Grifols Biologicals Inc. Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Purpura Treatment Market Share by Type: 2020 VS 2026
Figure 2. Non-thrombocytopenic Features
Figure 3. Thrombocytopenic Features
Figure 4. Global Purpura Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Use Case Studies
Figure 6. Clinic Use Case Studies
Figure 7. Household Case Studies
Figure 8. Other Case Studies
Figure 9. Purpura Treatment Report Years Considered
Figure 10. Global Purpura Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Purpura Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Purpura Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Purpura Treatment Market Share by Players in 2019
Figure 15. Global Top Purpura Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Purpura Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Purpura Treatment Revenue in 2019
Figure 17. North America Purpura Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Purpura Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Purpura Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Purpura Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Purpura Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Purpura Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Purpura Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
血栓性血小板減少性紫斑病治療の世界市場（～2026年） Market Analysis and Insights: Global Thrombotic Thrombocytopenic Purpura Treatment Market The global Thrombotic Thrombocytopenic Purpura Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Thrombotic Thrombocytop…- 特発性血小板減少性紫斑病（ITP）治療薬の世界市場（～2026年） ITP (idiopathic thrombocytopenic purpura) is a rare disease with low affliction rates. This disease leads to excessive bruising or bleeding due to the lack of blood platelets. It is also known as immune thrombocytopenia and can affect children and adults alike. Increasing demand for combination ther…
- 免疫性血小板減少性紫斑病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Immune Thrombocytopenic Purpura Therapeutics Market The global Immune Thrombocytopenic Purpura Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Immune Thrombocytopenic P…
- 統合失調感情障害治療の世界市場（～2026年） Types of schizoaffective disorders include manic, depressive, mixed, and schizoaffective disorders. The regional market for schizoaffective affective disorders is very common in North America, Europe and Asia Pacific. Market Analysis and Insights: Global Schizoaffective Disorders Treatment Market Th…
- 巨細胞性動脈炎治療の世界市場（～2026年） Giant cell arteritis is also known as temporal arteritis, is a type of disease which causes inflammation of medium and large vessels that occurs only in individuals older than 50 years of age. Seasonal variations in the incidence of giant cell arteritis treatment suggest a possible infective origin …